{
    "organizations": [],
    "uuid": "42fbd4de3cab4fa3580ce46c6f84150e2da4400e",
    "author": "Reuters Editorial",
    "url": "https://www.reuters.com/article/brief-teva-and-pg-have-agreed-to-termina/brief-teva-and-pg-have-agreed-to-terminate-the-pgt-healthcare-partnership-idUSFWN1RW0K5",
    "ord_in_thread": 0,
    "title": "BRIEF-Teva And P&G Have Agreed To Terminate The PGT Healthcare Partnership",
    "locations": [],
    "highlightText": "",
    "language": "english",
    "persons": [],
    "text": "April 19 (Reuters) - Procter & Gamble Co:\n* TEVA AND THE PROCTER & GAMBLE COMPANY HAVE AGREED TO TERMINATE THE PGT HEALTHCARE PARTNERSHIP\n* TEVA PHARMACEUTICAL INDUSTRIES LTD - NO SIGNIFICANT (MATERIAL) NET FINANCIAL TRANSFER BETWEEN TEVA AND P&G WILL RESULT FROM DISSOLUTION\n* TEVA PHARMACEUTICAL INDUSTRIES LTD - SEPARATION IS PLANNED TO TAKE EFFECT JULY 1, 2018 SUBJECT TO RECEIPT OF APPLICABLE REGULATORY APPROVALS\n* TEVA PHARMACEUTICAL INDUSTRIES LTD - SEPARATION IS NOT EXPECTED TO HAVE A MATERIAL EFFECT (IMPACT) ON TEVA’S 2018 FINANCIAL OUTLOOK\n* TEVA PHARMACEUTICAL INDUSTRIES LTD - IN 2017, COMBINED SALES FROM TEVA’S PGT OTC PRODUCTS AND TEVA NON-PGT OTC PRODUCTS WERE APPROXIMATELY $1 BILLION\n* TEVA PHARMACEUTICAL - WILL MERGE ITS OTC INTERESTS RETURNING FROM PGT WITH A PORTFOLIO OF OTC ASSETS ACQUIRED IN 2016 VIA ACTAVIS ACQUISITION Source text for Eikon: Further company coverage:\n ",
    "published": "2018-04-19T19:11:00.000+03:00",
    "crawled": "2018-04-20T11:22:07.000+03:00",
    "highlightTitle": "",
    "preprocessed_text": [
        "april",
        "reuters",
        "procter",
        "gamble",
        "co",
        "teva",
        "procter",
        "gamble",
        "company",
        "agreed",
        "terminate",
        "pgt",
        "healthcare",
        "partnership",
        "teva",
        "pharmaceutical",
        "industry",
        "ltd",
        "significant",
        "material",
        "net",
        "financial",
        "transfer",
        "teva",
        "p",
        "g",
        "result",
        "dissolution",
        "teva",
        "pharmaceutical",
        "industry",
        "ltd",
        "separation",
        "planned",
        "take",
        "effect",
        "july",
        "subject",
        "receipt",
        "applicable",
        "regulatory",
        "approval",
        "teva",
        "pharmaceutical",
        "industry",
        "ltd",
        "separation",
        "expected",
        "material",
        "effect",
        "impact",
        "teva",
        "financial",
        "outlook",
        "teva",
        "pharmaceutical",
        "industry",
        "ltd",
        "combined",
        "sale",
        "teva",
        "pgt",
        "otc",
        "product",
        "teva",
        "otc",
        "product",
        "approximately",
        "billion",
        "teva",
        "pharmaceutical",
        "merge",
        "otc",
        "interest",
        "returning",
        "pgt",
        "portfolio",
        "otc",
        "asset",
        "acquired",
        "via",
        "actavis",
        "acquisition",
        "source",
        "text",
        "eikon",
        "company",
        "coverage"
    ]
}